Last updated: 2026-09-05 14:22:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Indivior Pharmaceuticals, Inc. (INDV) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $34.94, with a market capitalisation of $4.11B and a P/E ratio of 11.62. Over the past 52 weeks, its price has ranged from $22.22 to $42.81. This page covers its latest market performance, valuation, price trends and company information.
$4.11B | |
$34.74 | |
$42.81 | |
$7.33 | |
$34.83 | |
820.32K | |
2.04M | |
11.62 | |
$42.81 | |
$22.22 | |
-- | |
-- |
Indivior Pharmaceuticals, Inc. (INDV) last closed at $34.83 as of 2026-09-04 23:31:00, unchanged from the previous close of $34.83.
During the latest regular trading session, INDV traded between $7.33 and $42.81, with a volume of 820.32K shares. The closing price was near the upper end and near the middle of its 52-week range.
Over the past seven days, Indivior Pharmaceuticals, Inc. (INDV) moved from $35.30 to $34.94, representing a decline of 1.01% ($0.36).
The stock traded between $34.31 and $35.95 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 2.06 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 61.8%
INDV is currently trading at $34.94, placing it 61.8% of the way from its 52-week low of $22.22 to its 52-week high of $42.81. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 838 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Indivior Pharmaceuticals, Inc. (INDV) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.